Pfizer agrees to Most-Favored-Nation pricing with the White House; Medicaid drug prices to be cut and “TrumpRx” discount site announced (price cuts start in 2026; Pfizer gets tariff relief and pledges $70B U.S. investment).

WINNERS

Category: Diversified Big Pharma

Reason: Deal narrows to Medicaid + MFN pricing on NEW launches; street sees limited earnings hit now, while regulatory overhang eases.

Examples: $PFE (policy clarity, tariff relief, DTC channel via TrumpRx); $JNJ (broad mix, minimal Medicaid concentration); $MRK (blockbusters skew to Medicare/commercial; clarity on launch pricing helps pipeline).

Category: Medicaid Managed Care (Insurers)

Reason: Lower net drug costs can improve Medicaid medical loss ratios and state-plan affordability.

Examples: $CNC (largest Medicaid MCO ...